2
|
Alexanian C, Liakos W, Toussi A, Kao J, Cheng MY, Wang EA, Nava J, Tran M, Marusina AI, Merleev AA, Leal AR, Fung MA, Le ST, Luxardi G, Maverakis E. Immune profiling of lupus miliaris disseminatus faciei and successful management with anti-tumour necrosis factor therapy. Clin Exp Dermatol 2021; 46:910-914. [PMID: 33864395 DOI: 10.1111/ced.14684] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Accepted: 04/12/2021] [Indexed: 11/29/2022]
Abstract
Lupus miliaris disseminatus faciei (LMDF) is a chronic inflammatory dermatosis of unknown aetiology, most often seen in young adults. Although many treatments for LMDF exist, treatment guidelines have not been developed, and response to therapy is generally unpredictable. We present the results of transcriptomic analysis of LMDF lesional skin, which revealed a variety of differentially expressed genes linking LMDF to alterations in innate and adaptive T helper 1 immunity. Immunohistochemical analysis was also performed, identifying similar changes in T-cell immune responses. Given evidence for increased tumour necrosis factor (TNF) pathway activity, our patient, who had previously been refractory to multiple treatments, was initiated on TNF inhibitor therapy with excellent response. This characterization of the LMDF immune response may lead to improved treatment of this condition.
Collapse
Affiliation(s)
- C Alexanian
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - W Liakos
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - A Toussi
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - J Kao
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - M Y Cheng
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - E A Wang
- Department of Dermatology, Stanford University School of Medicine, Palo Alto, CA, USA
| | - J Nava
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - M Tran
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - A I Marusina
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - A A Merleev
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - A R Leal
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - M A Fung
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA.,Department of, Pathology, University of California, Davis, Sacramento, CA, USA
| | - S T Le
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - G Luxardi
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| | - E Maverakis
- Departments of, Department of, Dermatology, University of California, Davis, Sacramento, CA, USA
| |
Collapse
|
3
|
Zhang W, Yu X, Yao Z. Case of acne-like lesion of cutaneous candidiasis in a healthy man. Int J Dermatol 2020; 59:e148-e150. [PMID: 32147819 DOI: 10.1111/ijd.14838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/20/2019] [Revised: 01/03/2020] [Accepted: 02/11/2020] [Indexed: 11/30/2022]
Affiliation(s)
- Wenqing Zhang
- Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.,Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Xia Yu
- Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.,Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Zhirong Yao
- Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.,Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| |
Collapse
|
4
|
Lupus Miliaris Disseminatus Faciei: A Case Report and Brief Literature Review. MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL 2018; 52:142-144. [PMID: 32595389 PMCID: PMC7315059 DOI: 10.14744/semb.2017.39306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/08/2017] [Accepted: 04/03/2017] [Indexed: 11/29/2022]
Abstract
Lupus miliaris disseminatus faciei (LMDF) is a rarely seen, granulomatous disease of the face with an unknown etiology. Clinically, the disease is characterized by monomorphic, reddish-brown, dome-shaped papules symmetrically distributed on the face. Histopathologically, a perifollicular caseating granuloma is the hallmark. A 20-year-old male patient was referred to our outpatient clinic with multiple papules distributed on his face, and he was diagnosed with LMDF based on histopathological examination. The patient was unresponsive to the oral tetracycline treatment; however, he was successfully treated with systemic dapsone and topical tacrolimus. This is a rare case of LMDF, which showed rapid improvement with dapsone therapy.
Collapse
|
5
|
Toda-Brito H, Aranha JMP, Tavares ES. Lupus miliaris disseminatus faciei. An Bras Dermatol 2018; 92:851-853. [PMID: 29364447 PMCID: PMC5786405 DOI: 10.1590/abd1806-4841.20174534] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2015] [Accepted: 04/13/2015] [Indexed: 11/21/2022] Open
Abstract
Lupus miliaris disseminatus faciei is a rare inflammatory dermatosis of unknown etiology that primarily affects young adults. Clinically, it is characterized by an asymptomatic papular eruption mainly involving the central face, typically on and around the eyelids. Characteristic histopathological features include dermal epithelioid cell granulomas with central necrosis and surrounding lymphocytic infiltrate with multinucleate giant cells. Lupus miliaris disseminatus faciei has a spontaneously resolving course, yet can be cosmetically debilitating given the location and potential for scarring. Treatment is difficult and there is a lack of controlled studies. We report a new case of lupus miliaris disseminatus faciei successfully treated with minocycline and systemic steroids, and briefly discuss its nosology and therapeutic options.
Collapse
|
7
|
Darakhshan S, Pour AB. Tranilast: a review of its therapeutic applications. Pharmacol Res 2014; 91:15-28. [PMID: 25447595 DOI: 10.1016/j.phrs.2014.10.009] [Citation(s) in RCA: 209] [Impact Index Per Article: 20.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/12/2014] [Revised: 10/29/2014] [Accepted: 10/30/2014] [Indexed: 12/14/2022]
Abstract
Tranilast (N-[3',4'-dimethoxycinnamoyl]-anthranilic acid) is an analog of a tryptophan metabolite. Initially, tranilast was identified as an anti-allergic agent, and used in the treatment of inflammatory diseases, such as bronchial asthma, atypical dermatitis, allergic conjunctivitis, keloids and hypertrophic scars. Subsequently, the results showed that it could be also effective in the management of a wide range of conditions. The beneficial effects of tranilast have also been seen in a variety of disease states, such as fibrosis, proliferative disorders, cancer, cardiovascular problems, autoimmune disorders, ocular diseases, diabetes and renal diseases. Moreover, several trials have shown that it has very low adverse effects and it is generally well tolerated by patients. In this review, we have attempted to accurately summarize previously published studies relating to the use of tranilast for a range of disorders and discuss the drug's possible mode of action. The major mode of the drug's efficacy appears to be the suppression of the expression and/or action of the TGF-β pathway, but the drug affects other factors as well. The findings presented in this review demonstrate the potential of tranilast for the control of a vast array of pathological situations, furthermore, it is a prescribed drug without severe side effects.
Collapse
Affiliation(s)
- Sara Darakhshan
- Department of Biology, Faculty of Science, Razi University, Kermanshah, Iran
| | - Ali Bidmeshki Pour
- Department of Biology, Faculty of Science, Razi University, Kermanshah, Iran.
| |
Collapse
|